Tatva Chintan Pharma Chem Limited

NSEI:TATVA Stock Report

Market Cap: ₹24.0b

Tatva Chintan Pharma Chem Future Growth

Future criteria checks 5/6

Tatva Chintan Pharma Chem is forecast to grow earnings and revenue by 45.5% and 23% per annum respectively. EPS is expected to grow by 45.3% per annum. Return on equity is forecast to be 10.9% in 3 years.

Key information

45.5%

Earnings growth rate

45.3%

EPS growth rate

Chemicals earnings growth20.8%
Revenue growth rate23.0%
Future return on equity10.9%
Analyst coverage

Low

Last updated30 Jul 2024

Recent future growth updates

Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Jul 27
Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Recent updates

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Sep 26
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Aug 29
Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Jul 27
Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

May 11
Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

Apr 04
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Jan 26
These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

May 10
Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Jul 28
Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Jun 17
Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

May 03
Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Dec 06
Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Earnings and Revenue Growth Forecasts

NSEI:TATVA - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20276,652909234N/A1
3/31/20266,759913103N/A3
3/31/20255,070507-278N/A3
6/30/20243,846261N/AN/AN/A
3/31/20243,935304-305980N/A
12/31/20234,198377N/AN/AN/A
9/30/20234,562459-5901,145N/A
6/30/20234,496452N/AN/AN/A
3/31/20234,236455-1,753278N/A
12/31/20223,976460N/AN/AN/A
9/30/20223,817572-1,480-99N/A
6/30/20224,152825N/AN/AN/A
3/31/20224,336959-689202N/A
12/31/20214,438995N/AN/AN/A
9/30/20214,192976N/AN/AN/A
6/30/20213,557687N/AN/AN/A
3/31/20213,004523-13197N/A
3/31/20202,632378-229253N/A
3/31/20192,063205-2474N/A
3/31/20181,358123N/A126N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TATVA's forecast earnings growth (45.5% per year) is above the savings rate (6.7%).

Earnings vs Market: TATVA's earnings (45.5% per year) are forecast to grow faster than the Indian market (17.3% per year).

High Growth Earnings: TATVA's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: TATVA's revenue (23% per year) is forecast to grow faster than the Indian market (10.1% per year).

High Growth Revenue: TATVA's revenue (23% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: TATVA's Return on Equity is forecast to be low in 3 years time (10.9%).


Discover growth companies